Login
Agenda
9 - 12 March 2010
ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)
9 -11 June 2010
EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)
12-15 June 2010
ESA European Society of Anaesthesiology - Helsinki (Finland)
18-22 September 2010
ERS European Respiratory Society - Barcellona (Spain)
9 -13 October 2010
ESICM European Society of Intensive Care Medicine - Barcellona (Spain)
> International events
| BRONCHOALVEOLAR LAVAGE FOR DIAGNOSING PNEUMONIA IN MECHANICALLY VENTILATED PATIENTS |
|
|
|
| Friday, 06 March 2009 | |
|
Estella A, Monge MI, Pérez Fontaiña L, Sainz de Baranda A, Galá MJ, Moreno E. Unidad de Cuidados Intensivos. Hospital del SAS de Jerez. Jerez. Cádiz. España
Med Intensiva. 2008 Dec;32(9):419-23.
OBJECTIVE: To evaluate the diagnostic role of bronchoalveolar lavage (BAL) in mechanically ventilated patients with suspected pneumonia and to describe the clinical outcome in the different kinds of pneumonia in critically ill patients. DESIGN: Descriptive study. SETTING: A 17-bed medical and surgical intensive care unit. PATIENTS: Mechanically ventilated patients admitted to the ICU from November 2003 to March 2006 with suspected pneumonia who underwent bronchoscopy with BAL. INTERVENTIONS: BAL was performed by fiberoptic bronchoscopy with three aliquots of 50 ml sterile normal saline. Recovered BAL fluid was pro-cessed for microbiologic analysis. MAIN VARIABLES OF INTEREST: Age, APACHE II score within the first 24 hours of admission, time on mechanical ventilation, ICU length of stay, mortality, and isolated bacteria were analyzed. RESULTS: A total of 96 cases of suspected pneumonia with BAL were recruited, including 4 groups: community associated pneumonia (CAP), 12 cases, early-onset ventilator-associated pneumonia (VAP), 26 cases, late-onset ventilator-associated pneumonia, 43 cases, and immunocompromised patients, 15 cases. BAL was positive (> 10000 ufc/ml) in 40 (41.7%) patients (2, 16, 17 and 5 patients with CAP, early-onset VAP, late-onset VAP and immunocompromised, respectively). Mortality was 33.3%, 26.9%, 25.6% and 73.3% in CAP, early-onset VAP, late-onset VAP and immunocompromised patients respectively. CONCLUSIONS: The low incidence of positive BAL in the CAP group supports using BAL only for particularly severe, selected cases. Mortality was very high in the immunocompromised patients. In the light of our personal experience, BAL is most useful in the diagnosis of pneumonia in the group of patients with VAP.
|
|
| Last Updated ( Friday, 06 March 2009 ) |
| < Prev | Next > |
|---|
![]() |
| Select and watch from the following webinars |












